ArticleEuropean urology2012

Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.

Robert J Klein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.